EG19189A - The use of asymetric membranes in delivery devices - Google Patents

The use of asymetric membranes in delivery devices

Info

Publication number
EG19189A
EG19189A EG42189A EG42189A EG19189A EG 19189 A EG19189 A EG 19189A EG 42189 A EG42189 A EG 42189A EG 42189 A EG42189 A EG 42189A EG 19189 A EG19189 A EG 19189A
Authority
EG
Egypt
Prior art keywords
delivery devices
membranes
asymetric
asymetric membranes
diffusion
Prior art date
Application number
EG42189A
Other languages
English (en)
Inventor
John R Cardinal
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of EG19189A publication Critical patent/EG19189A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
EG42189A 1988-08-30 1989-08-29 The use of asymetric membranes in delivery devices EG19189A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23837188A 1988-08-30 1988-08-30

Publications (1)

Publication Number Publication Date
EG19189A true EG19189A (en) 1994-11-30

Family

ID=22897578

Family Applications (1)

Application Number Title Priority Date Filing Date
EG42189A EG19189A (en) 1988-08-30 1989-08-29 The use of asymetric membranes in delivery devices

Country Status (26)

Country Link
EP (1) EP0357369B1 (de)
JP (1) JPH07112971B2 (de)
KR (1) KR920008701B1 (de)
CN (2) CN1058387C (de)
AT (1) ATE89162T1 (de)
AU (1) AU615104B2 (de)
CA (1) CA1338552C (de)
CZ (1) CZ277763B6 (de)
DD (1) DD289466A5 (de)
DE (1) DE68906488T2 (de)
DK (1) DK175178B1 (de)
EG (1) EG19189A (de)
ES (1) ES2041006T3 (de)
FI (1) FI102515B1 (de)
HU (1) HU222245B1 (de)
IE (1) IE62859B1 (de)
IL (1) IL91398A (de)
MX (1) MX173942B (de)
MY (1) MY104183A (de)
NO (1) NO179232C (de)
NZ (1) NZ230470A (de)
PL (1) PL163079B1 (de)
PT (1) PT91560B (de)
RU (2) RU1837873C (de)
YU (1) YU47422B (de)
ZA (1) ZA896586B (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4962128A (en) * 1989-11-02 1990-10-09 Pfizer Inc. Method of treating anxiety-related disorders using sertraline
EP0542926B1 (de) * 1990-08-07 1995-02-15 Pfizer Inc. Verwendung von interfacial polymerisierten membranen in abgabevorrichtungen
ATE106015T1 (de) * 1990-09-28 1994-06-15 Pfizer Wirkstoffabgabevorrichtung die ein hydrophobisches mittel enthält.
ZA933725B (en) * 1992-05-28 1993-12-15 Elan Corp Plc Tablet formulation
TW235239B (de) * 1992-11-20 1994-12-01 Pfizer
JP2847326B2 (ja) * 1992-11-30 1999-01-20 ファイザー・インク． 支持された液体膜送達デバイス
US5358502A (en) * 1993-02-25 1994-10-25 Pfizer Inc PH-triggered osmotic bursting delivery devices
US5798119A (en) * 1995-06-13 1998-08-25 S. C. Johnson & Son, Inc. Osmotic-delivery devices having vapor-permeable coatings
EP0811374A1 (de) 1996-05-29 1997-12-10 Pfizer Inc. Formulierung für ein Kombinationspräparat mit Cetirizin und Pseudoephedrin
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
EA002482B1 (ru) * 1997-07-01 2002-06-27 Пфайзер Инк. Соли сертралина и лекарственные формы с длительным высвобождением сертралина
CA2290969C (en) * 1997-07-01 2004-02-17 Pfizer Products Inc. Delayed-release dosage forms of sertraline
DE19814256A1 (de) * 1998-03-31 1999-10-07 Asta Medica Ag Feste, schnellzerfallende Cetirizin-Formulierungen
SI1131070T1 (sl) * 1998-11-12 2008-12-31 Smithkline Beecham Plc Farmacevtski sestavek za modificirano sproĺ äśanje senzibilizatorja za inzulin in metformina
AU4709000A (en) * 1999-05-17 2000-12-05 Dow Chemical Company, The Process for making cellulose ether capsules with organic acids
US20030175349A1 (en) * 2001-01-30 2003-09-18 Council Of Scientific And Industrial Research Pharmaceutical compostion for extended/sustained release of a therapeutically active ingredient
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
PL372904A1 (en) 2002-04-04 2005-08-08 Pfizer Products Inc. Palatable chewable tablet
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
US7611728B2 (en) * 2003-09-05 2009-11-03 Supernus Pharmaceuticals, Inc. Osmotic delivery of therapeutic compounds by solubility enhancement
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
NZ589750A (en) 2004-10-21 2012-07-27 Aptalis Pharmatech Inc Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US20060105038A1 (en) * 2004-11-12 2006-05-18 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions prepared by coacervation
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
WO2007002872A2 (en) * 2005-06-29 2007-01-04 Alza Corporation Semi-permeable compositions providing reduced drying time for osmotic dosage forms
EA017290B1 (ru) 2005-11-28 2012-11-30 Домейн Раша Инвестментс Лимитед Композиции на основе ганаксолона
EP2248541B1 (de) 2009-05-07 2018-10-31 Biotronik Ag Medikamentenbeschichteter ballonkatheter und verfahren zur herstellung desselben
CN101773484B (zh) * 2009-05-12 2013-12-25 沈阳药科大学 胃漂浮渗透泵型非匀质膜胶囊缓控释系统及其制备方法
WO2011039686A1 (en) 2009-09-30 2011-04-07 Pfizer Inc. Latrepirdine oral sustained release dosage forms
JP5309262B2 (ja) 2009-12-02 2013-10-09 アプタリス ファーマ リミテッド フェキソフェナジン・マイクロカプセル及びそれを含む組成物
US10898865B2 (en) * 2013-01-31 2021-01-26 American University In Cairo (AUC) Polymer-carbon nanotube nanocomposite porous membranes
JP6041823B2 (ja) 2013-03-16 2016-12-14 ファイザー・インク トファシチニブの経口持続放出剤形
WO2021014360A1 (en) 2019-07-23 2021-01-28 Pfizer Inc. Oral modified release dosage forms
IL292925A (en) 2019-11-14 2022-07-01 Pfizer 1-(((4s,3s,2s)-3-ethyl-4-fluoro-5-oxopyrrolidin-2-yl)methoxy)-7-methoxyisoquinoline-6-carboxamide combinations and oral dosage forms
JP2023517346A (ja) 2020-02-03 2023-04-25 ジョンソン アンド ジョンソン コンシューマー インコーポレイテッド セチリジンを含む単層チュアブル錠剤

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL271831A (de) * 1960-11-29
DE3167521D1 (en) * 1981-01-22 1985-01-17 Capsugel Ag A process for producing a pharmaceutical capsule having enteric properties
NZ206600A (en) * 1983-05-11 1987-01-23 Alza Corp Osmotic drug delivery device
GB8322007D0 (en) * 1983-08-16 1983-09-21 Wellcome Found Pharmaceutical delivery system
US4684524A (en) * 1984-03-19 1987-08-04 Alza Corporation Rate controlled dispenser for administering beneficial agent
DE3485618D1 (de) * 1984-08-17 1992-04-30 Wellcome Found Zusammensetzung zur kontrollierten abgabe eines wirkstoffes und ihre herstellung.
US4837111A (en) * 1988-03-21 1989-06-06 Alza Corporation Dosage form for dispensing drug for human therapy

Also Published As

Publication number Publication date
RU1837873C (ru) 1993-08-30
EP0357369A3 (de) 1991-10-02
AU4089189A (en) 1990-05-31
DD289466A5 (de) 1991-05-02
DE68906488T2 (de) 1993-09-09
KR900002821A (ko) 1990-03-23
YU47422B (sh) 1995-03-27
NO179232B (no) 1996-05-28
FI894046A (fi) 1990-03-01
PL163079B1 (pl) 1994-02-28
AU615104B2 (en) 1991-09-19
MX173942B (es) 1994-04-11
FI102515B (fi) 1998-12-31
IL91398A (en) 1994-05-30
NO893450D0 (no) 1989-08-29
DK175178B1 (da) 2004-06-28
EP0357369B1 (de) 1993-05-12
ATE89162T1 (de) 1993-05-15
FI102515B1 (fi) 1998-12-31
CN1125573A (zh) 1996-07-03
PT91560A (pt) 1990-03-30
PT91560B (pt) 1995-05-04
EP0357369A2 (de) 1990-03-07
DK424489A (da) 1990-03-01
NZ230470A (en) 1991-06-25
DE68906488D1 (de) 1993-06-17
CS501189A3 (en) 1992-12-16
DK424489D0 (da) 1989-08-29
IL91398A0 (en) 1990-04-29
CZ277763B6 (en) 1993-04-14
ZA896586B (en) 1991-04-24
IE62859B1 (en) 1995-03-08
HU222245B1 (hu) 2003-05-28
FI894046A0 (fi) 1989-08-29
CN1042072A (zh) 1990-05-16
KR920008701B1 (ko) 1992-10-08
CA1338552C (en) 1996-08-27
NO179232C (no) 1996-09-04
NO893450L (no) 1990-03-01
HUT74086A (en) 1996-11-28
JPH02174713A (ja) 1990-07-06
ES2041006T3 (es) 1993-11-01
IE892771L (en) 1990-02-28
CN1058387C (zh) 2000-11-15
MY104183A (en) 1994-02-28
JPH07112971B2 (ja) 1995-12-06
RU2093147C1 (ru) 1997-10-20
YU165789A (en) 1992-05-28

Similar Documents

Publication Publication Date Title
EG19189A (en) The use of asymetric membranes in delivery devices
BR9407238A (pt) Dispositivo implantável de fornecimento de droga
ES8705240A1 (es) Dispositivo osmotico para la administracion controlada de unagente benefico a un ambiente de utilizacion
ATE108648T1 (de) Implantierbare abgabevorrichtung.
DK288987A (da) Et afgivelsessystem til doseringsformerne forhalet afgivelse, samt dettes fremstilling
DE9190107U1 (de) Abgabe-Vorrichtung mit durch Grenzflächen-Polymerisation erhaltenen Membranen
NO165378C (no) Medikamentavgivende innretning for implantering i menneskekroppen.
ES2009014A6 (es) Sistema de suministro de unidades multiples.
DE69002034D1 (de) Vorrichtung mit gesteuerter wirkstoffabgabe.
DE68901619D1 (de) Osmotisches system zur verabreichung von verduennten loesungen.
DK0746354T3 (da) Vaccinetilførselssystem
DE58906222D1 (de) Fadenliefervorrichtung.
DE58906848D1 (de) Fadenspeicher- und -liefervorrichtung.
DK0483273T3 (da) Ionoforholdig afgivelsesindretning
DK594889D0 (da) Reservoir til styret medikamentafgivelse, indretning indeholdende saadant reservoir samt fremgangsmaade til fremstilling og anvendelse af indretningen
GR870214B (en) Device for splitting fluid and stable compounds,new type washer witha larger diameter placed at the accelerating membrane